| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442974 | European Journal of Cancer | 2014 | 12 Pages |
Abstract
PFSR-18 was strongly correlated and discriminated patients with better OS from the poorer prognosis patients. An earlier end-point, PFSR-9 was also strongly correlated to OS with better discriminating capacity. The results were independently validated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hasan Baktiar, Greillier Laurent, Pallis Athanasios, Menis Jessica, Gaafar Rabab, Sylvester Richard, Fennell Dean A., Baas Paul, Surmont Veerle, Van Meerbeeck Jan P., O'brien Mary E.R.,